Abital is much more than a cluster of first-class drugs for treating the most urgent needs of patients with Parkinson’s and CNS diseases. It is a vision to serve the entire continuum of CNS care – from early diagnostics to therapeutics of late stage patients.
Abital’s vision is the outcome of 30 years of scientific knowledge, sequential market successes, and an endless passion by its founders. This passion is driven by a desire to make the world a better place for tens of millions who long for better care.
Abital projects includes important breakthrough innovations
The most exciting pharma pipleline company in the world.
Prof. Youdim’s team includes the finest researchers in the world.